imbrave150研究

Ad

TECENTRIQ® (atezolizumab) - Official Physician Website

Visit The HCP Site to Learn About Efficacy, Safety, MOA, and Dosing Info For TECENTRIQ®. View Information On TECENTRIQ® Combination Therapy & Resources For Physicians On HCP Site.

中国亚群突破24个月！IMbrave150研究OS最新数据公布，“T+A”方案显著改...

Jun 24, 2024 · IMbrave150是一项全球性III期、多中心、开放性研究，旨在评估“T+A”方案对比 索拉非尼 在既往未接受过系统性治疗的不可切除HCC患者中的作用。

IMbrave150: Efficacy and Safety of Atezolizumab plus ... - PubMed

Nov 28, 2022 · Abstract Introduction: The phase III IMbrave150 study established atezolizumab + bevacizumab as standard of care in patients with unresectable hepatocellular carcinoma (HCC). This exploratory analysis r...

罗氏IMbrave 150 Ⅲ期研究中国亚群数据：T+A免疫联合疗法显著提高肝细...

IMbrave150是一项在501名既往未接受过系统性治疗的不可切除的肝细胞癌患者中开展的全球性Ⅲ期、多中心、开放性研究。 患者按照2:1的比例随机接受“T+A”联合治疗或索拉非尼治疗。

IMbrave150: Updated overall survival (OS) data from a global ...

Jan 22, 2021 · IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectabl...

Updated efficacy and safety data from IMbrave150 ...

IMbrave150 was carried out in accordance with the Interna-tional Conference on Harmonisation guidelines for Good Clinical Practice and the principles of the Declaration of Helsinki. All patients gave written informed ...

IMbrave 150: Updated Outcomes | CancerNetwork

Sep 9, 2024 · Home > Between The Lines > IMbrave150: Atezolizumab plus Bevacizumab in HCC: Efficacy Data and Clinical Practice Implications

Updated efficacy and safety data from IMbrave150 ...

Apr 1, 2022 · The primary analysis of IMbrave150 showed that atezolizumab plus bevacizumab had significantly greater benefits than sorafenib in patients with advanced hepatocellular carcinoma, but survival data were n...

Ad

TECENTRIQ® (atezolizumab) - Official Physician Website

Visit The Official Physician Site To Find Resources & Get More Information On TECENTRIQ®. View Information On TECENTRIQ® Combination Therapy & Resources For Physicians On HCP Site.